However, we have confirmed that cardiac ET-1 levels are not different before and immediately after prolonged ischemia in the case of SM-19712 treatment [18], suggesting the possibility that ET-1 release during myocardial ischemia is reduced by ECE inhibition. Here, EDN1 is linked to ischemia.